Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine in the Treatment of Fibromyalgia: a Randomized Non-inferiority Clinical Trial (FIBROSTIM)

NCT07203339 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.

NCT NCT07203339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07203339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine in the Treatment of Fibromyalgia: a Randomized Non-inferiority Clinical Trial (FIBROSTIM)
Lead sponsor
Hospital de Clinicas de Porto Alegre
Phase
Not applicable
Overall status
Recruiting
Start date
September 30, 2025
Completion date
December 31, 2028
Enrollment
610 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bdnf, duloxetine, eeg, fibromyalgia (fm), tdcs